Showing results (351-360 of 366) with videos related to

Sort By:
Pageof 37
JAMA Oncology|April 20, 2023
Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology/RTOG 0631 Randomized Clinical TrialSamuel Ryu, Snehal Deshmukh, Robert D Timmerman, et al.
International Journal of Radiation Oncology, Biology, Physics|August 19, 2025
Self-Perceived Hearing Outcomes with Radiation and Cisplatin or Radiation and Cetuximab for Patients with HPV-Positive Oropharyngeal Cancer - Results from xxxxxChristina L Runge, Jessica A Lyness, Maura L Gillison, et al.
The American Journal of Cardiology|April 26, 2016
Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial)Marco Metra, Robert J Mentz, Adrian F Hernandez, et al.
Environmental Health Perspectives|July 31, 2018
Comprehensive Analyses and Prioritization of Tox21 10K Chemicals Affecting Mitochondrial Function by in-Depth Mechanistic StudiesMenghang Xia, Ruili Huang, Qiang Shi, et al.
International Journal of Radiation Oncology, Biology, Physics|September 14, 2017
A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck CancerJohn A Vargo, Matthew C Ward, Jimmy J Caudell, et al.
Circulation|May 20, 2015
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) StudyMichael M Givertz, Kevin J Anstrom, Margaret M Redfield, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2024
Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Stage III Non-Small Cell Lung CancerFeng-Ming Spring Kong, Chen Hu, Daniel A Pryma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2022
Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell CarcinomaTrisha M Wise-Draper, Shuchi Gulati, Sarah Palackdharry, et al.
JAMA Otolaryngology-- Head & Neck Surgery|December 4, 2025
Treatment Interruption and Outcomes in Head and Neck Cancer: A Secondary Analysis of 3 Randomized Clinical TrialsLaila A Gharzai, Emily Morris, Matthew J Schipper, et al.
The Lancet. Oncology|February 29, 2024
Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysisLaila A Gharzai, Emily Morris, Krithika Suresh, et al.
Pageof 37